Drug intelligence / Profile preview

medium-chain diacylglycerol oil

Development stage
Unknown
Lead developer
Kao
Modality
Small Molecules
Administration
Oral
01

Overview

Medium-chain diacylglycerol (MCDAG) oil is a functional dietary lipid composed primarily of diacylglycerols (DAG) containing medium-chain fatty acids (MCFA), typically caprylic (C8) and capric (C10) acids. Unlike conventional triacylglycerols (TAG), the 1,3-diacylglycerol isoform in MCDAG is metabolized differently in the gastrointestinal tract. While it is hydrolyzed into 1-monoglycerides and free fatty acids, these products are poorly re-esterified into TAG within enterocytes, leading to reduced chylomicron formation and lower postprandial blood lipid levels. Furthermore, the MCFAs released are transported directly to the liver via the portal vein for rapid beta-oxidation rather than being stored in adipose tissue. These metabolic characteristics make MCDAG a candidate for the management of obesity, hypertriglyceridemia, and metabolic syndrome by promoting fat oxidation and suppressing body fat accumulation.

Other names
MCDAGmedium-chain diacylglycerolMC-DAGmedium-chain diglycerides
02

Targets

DGAT1 (Diacylglycerol O-acyltransferase 1)

Beyond the preview

Go deeper on medium-chain diacylglycerol oil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on medium-chain diacylglycerol oil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call